IL17A and renal carcinoma: Hence, we speculated that the increased proportion of activated memory CD4 T cells contributed to inferior survival outcomes in renal cancer through enhanced secretion of IL-17, which might be one of the possible mechanisms and needed to be validated further in the future investigations.